UK and EU news re CBD

UK and EU news re CBD

The CBD market was built from the ground up by small British businesses, but it's about to be stolen by government-backed companies.

Over about the last five years, small British businesses have built the CBD market from zero to hundreds of millions in annual sales. It’s been driven by rapidly changing attitudes towards cannabis and a realization that many of its medicinal benefits could be available legally by using traditional hemp extracts.

Big business, the established supplement and health food companies weren’t interested. They saw the stigma around cannabis before they saw the changing attitudes.

Now it’s all very different. Millions of people are using CBD. All the big multiples are stocking it. It’s become a media fascination and many people say they gain great benefit from it. Suddenly, big business and all the regulators are interested. Suddenly those who weren’t bothered previously are cautioning about all sorts of dangers and concerns.

They don’t actually have any evidence of CBD products causing any harm but clearly they don’t think these small, independent businesses can be trusted anymore. Of course, the truth is they want a slice of the action – or preferably all of the action if they can get their chums in government and the bureaucracy to step in and assist with their plans.

In fact the British CBD industry has been a model of responsible self-regulation. Two trade associations, the CTA and CannaPro, represent virtually all the leading UK suppliers and maintain high levels of quality control and trading standards, including regular reporting of non-compliant businesses to the MHRA.

But in June this year, the Centre for Medicinal Cannabis (CMC) published a sensational report alleging that most of the CBD on the market was very poor quality, contained illegal levels of THC and some contained no CBD at all. Its report was presented as some sort of independent, academic study
that should be regarded as science. It wasn’t. It was a cheap marketing
stunt. Sure
enough, just a few weeks later it announced that all its members’
products were good quality and there was no problem with them.


Now the CMC has thrown itself in with the EU and is backing the classification of CBD products as ‘novel foods’, meaning that any business selling CBD would have to apply for an authorization at a cost of at least £250,000 in a process taking perhaps two years to complete. The CMC has also aligned itself with an interpretation of the law on THC levels in CBD products which is completely at odds with the established industry. It has sided with the Home Office that there cannot be any THC at all, whereas the industry relies on a definition of ‘exempt products’ in the Misuse of Drugs Regulations 2001 which permits up to 1mg of THC in each container.

As Brexit approaches, the Food Standards Agency (FSA) is expected to
issue guidance on enforcement of the novel foods classification. If it
acts before Brexit then the position will be carried over in the
Withdrawal Agreement. And now the CMC has launched yet another trade
body, the Association for the Cannabinoid Industry, (ACI) which it is implying will enable CBD suppliers to enjoy a ‘grace period’ from FSA enforcement.

It would be unlawful for the FSA to make any arrangements or offer
any ‘grace period’ to CMC or ACI members that is not available to any
other business. Mike Harlington of the CTA tried this on before,
claiming he had made special arrangements with the FSA for CTA members
only. None of this is true. These claims are confidence tricks but the
CMC/ACI is pushing it with the requirement to sign up to membership at a
cost said to be between £10,000 and £50,000 per year, completely
prohibitive for the small businesses that have worked so hard to develop
this industry.

The Centre For Medicinal Cannabis Is A Wolf In Sheep’s Clothing, The ‘Big Pharma’ Of British Medicinal Cannabis And CBD.

The CMC appeared sometime in 2018 announcing itself as the
UK’s first and only industry membership body for businesses and
investors operating in cannabis based medicinal products (CBMPs) and
cannabidiol (CBD) wellness markets.
This, of course, is

nonsense. It’s about the fifth or sixth to set itself up as a trade
body in this market and it’s certainly not the only. Between them, the
CTA and CannaPro represent hundreds of businesses with millions of
satisfied customers. The CMC has only a handful of members.

What the CMC/ACI does have is a great deal of money from its backer,
the multimillionaire Paul Birch and a great deal of influence from
ex-David Cameron ‘fixer’, Steve Moore, who knows all the right people in
all the establishment elites and knows how to pull their strings. In
just a few short months it has pumped a fortune into PR and media
relations and made itself the go to source for anything on medicinal
cannabis and CBD. It has also bought and paid for a large number of
highly qualified people with impressive credentials who inevitably carry
great weight with the authorities. Its ambitions are clear. It intends
to destroy the small businesses that built this market and seize it all
for itself –  and it looks as though it may well succeed.

CannaPro spoke with the FSA earlier this week. For the moment, the
FSA cannot act as we are in election ‘purdah’, the civil service can’t
really do anything except keep the status quo but that will all change
after the election. Then, depending on the new government, it may move
rapidly to commence enforcement. What this will mean is impossible to
predict but almost certainly the multiples will take stock off the
shelves unless some interim arrangements are agreed. Those with retail
premises will be in the most immediate danger, online sellers will be in
a better position but if Trading Standards officers try to seize stock,
they have extraordinary powers and trying to obstruct them may result
in arrest.

Of course, the novel foods classification is fake and a lot of evidence has been presented to prove this but it is simply being dismissed. It’s rather like the way the medical establishment dismisses the evidence on medicinal cannabis. If these institutions don’t like evidence they simply ignore it. For obvious reasons, it suits the CMC to get behind the novel food scam but the result for consumers will be a lot less choice and probably substantial price rises. It’s also very bad news for British CBD businesses. A lot of people are likely to lose their jobs.

Leave a Reply

All fields are required

Name:
E-mail: (Not Published)
Comment: